Neuronal ganglionic acetylcholine receptor autoimmunity

Steven Vernino, Vanda A. Lennon

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

We have developed and validated an assay to detect serum antibodies specific for the ganglionic AChR. The assay uses ganglionic AChR solubilized from membranes of the human neuroblastoma cell line (IMR-32) as antigen. The ganglionic AChR is radiolabeled by complexing with 125I-epibatidine. Among patients with acquired dysautonomia, seropositivity is highly associated with the diagnosis of idiopathic or paraneoplastic autonomic neuropathy and can distinguish these disorders from other forms of autonomic dysfunction. Ganglionic AChR binding antibodies are detectable in 50% of patients with subacute autoimmune autonomic neuropathy (AAN). These patients often have a high antibody value (>0.2 nmol/L). Lower values (0.05-0.20 nmol/L) are found in ∼10% of patients with limited AAN.

Original languageEnglish (US)
Pages (from-to)211-214
Number of pages4
JournalAnnals of the New York Academy of Sciences
Volume998
DOIs
StatePublished - 2003

Fingerprint

Cholinergic Receptors
Autoimmunity
epibatidine
Antibodies
Assays
Paraneoplastic Polyneuropathy
Primary Dysautonomias
Neuroblastoma
Cells
Membranes
Antigens
Cell Line
Serum

Keywords

  • Autonomic neuropathy
  • Gastrointestinal dysmotility
  • Orthostatic hypotension
  • Thymoma

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Neuronal ganglionic acetylcholine receptor autoimmunity. / Vernino, Steven; Lennon, Vanda A.

In: Annals of the New York Academy of Sciences, Vol. 998, 2003, p. 211-214.

Research output: Contribution to journalArticle

@article{77b9d7942c844335a25debda24a17581,
title = "Neuronal ganglionic acetylcholine receptor autoimmunity",
abstract = "We have developed and validated an assay to detect serum antibodies specific for the ganglionic AChR. The assay uses ganglionic AChR solubilized from membranes of the human neuroblastoma cell line (IMR-32) as antigen. The ganglionic AChR is radiolabeled by complexing with 125I-epibatidine. Among patients with acquired dysautonomia, seropositivity is highly associated with the diagnosis of idiopathic or paraneoplastic autonomic neuropathy and can distinguish these disorders from other forms of autonomic dysfunction. Ganglionic AChR binding antibodies are detectable in 50{\%} of patients with subacute autoimmune autonomic neuropathy (AAN). These patients often have a high antibody value (>0.2 nmol/L). Lower values (0.05-0.20 nmol/L) are found in ∼10{\%} of patients with limited AAN.",
keywords = "Autonomic neuropathy, Gastrointestinal dysmotility, Orthostatic hypotension, Thymoma",
author = "Steven Vernino and Lennon, {Vanda A.}",
year = "2003",
doi = "10.1196/annals.1254.023",
language = "English (US)",
volume = "998",
pages = "211--214",
journal = "Annals of the New York Academy of Sciences",
issn = "0077-8923",
publisher = "Wiley-Blackwell",

}

TY - JOUR

T1 - Neuronal ganglionic acetylcholine receptor autoimmunity

AU - Vernino, Steven

AU - Lennon, Vanda A.

PY - 2003

Y1 - 2003

N2 - We have developed and validated an assay to detect serum antibodies specific for the ganglionic AChR. The assay uses ganglionic AChR solubilized from membranes of the human neuroblastoma cell line (IMR-32) as antigen. The ganglionic AChR is radiolabeled by complexing with 125I-epibatidine. Among patients with acquired dysautonomia, seropositivity is highly associated with the diagnosis of idiopathic or paraneoplastic autonomic neuropathy and can distinguish these disorders from other forms of autonomic dysfunction. Ganglionic AChR binding antibodies are detectable in 50% of patients with subacute autoimmune autonomic neuropathy (AAN). These patients often have a high antibody value (>0.2 nmol/L). Lower values (0.05-0.20 nmol/L) are found in ∼10% of patients with limited AAN.

AB - We have developed and validated an assay to detect serum antibodies specific for the ganglionic AChR. The assay uses ganglionic AChR solubilized from membranes of the human neuroblastoma cell line (IMR-32) as antigen. The ganglionic AChR is radiolabeled by complexing with 125I-epibatidine. Among patients with acquired dysautonomia, seropositivity is highly associated with the diagnosis of idiopathic or paraneoplastic autonomic neuropathy and can distinguish these disorders from other forms of autonomic dysfunction. Ganglionic AChR binding antibodies are detectable in 50% of patients with subacute autoimmune autonomic neuropathy (AAN). These patients often have a high antibody value (>0.2 nmol/L). Lower values (0.05-0.20 nmol/L) are found in ∼10% of patients with limited AAN.

KW - Autonomic neuropathy

KW - Gastrointestinal dysmotility

KW - Orthostatic hypotension

KW - Thymoma

UR - http://www.scopus.com/inward/record.url?scp=0141839039&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0141839039&partnerID=8YFLogxK

U2 - 10.1196/annals.1254.023

DO - 10.1196/annals.1254.023

M3 - Article

VL - 998

SP - 211

EP - 214

JO - Annals of the New York Academy of Sciences

JF - Annals of the New York Academy of Sciences

SN - 0077-8923

ER -